Major players in the research antibodies and reagents market are Becton Dickinson and Company, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann La-Roche Ltd., Merck KGaA, PerkinElmer Inc., Lonza Group AG, Abcam plc., GenScript Biotech Corporation and Bio-Techne Corporation.
The global research antibodies and reagents market is expected to grow from $12.40 billion in 2021 to $13.19 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $16.90 billion in 2026 at a CAGR of 6.4%
The research antibodies and reagents market consist of sales of research antibodies, reagents and related services by entities (organizations, sole traders and partnerships) that produce research antibodies and reagents to diagnose and treat different diseases.The revenue generated by the market includes the sales of research antibodies in the form of primary and secondary antibodies extracted from sources such as mouse, rabbit and others, and reagents like stains & dyes, media & serum, fixatives, buffers, probe, solvents, enzymes and others.
The companies involved in the research antibodies and reagents market are primarily engaged in developing antibodies and reagents for the application of proteomics, genomics, drug discovery and development by the pharmaceutical & biotechnology industries, academic & research institutes and contract research organizations.
The main types of technologies in research antibodies and reagents are western blot, immunofluorescence, immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA), multiplex immunosorbent assay, immunoprecipitation and others.The western blot, also known as western blotting, is a molecular biology and immunogenetics analytical technique for detecting specific proteins in a sample of tissue homogenate or extract.
The different applications include proteomics, drug discovery & development, genomics and implemented in various sectors such as pharmaceutical & biotechnology industry, academic & research institutes, contract research organizations (CROs).
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Increasing investment in medical and health research and development (R&D) is predicted to contribute to the growth of the research antibodies and reagents market.In the field of life science research, antibodies and reagents are essential components for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing.
According to the American Association for the Advancement of Science’s (AAAS) statistics published in December 2019, the total investment in medical and health research in the US grew by 6.4%. The health industry invested $129.5 billion (66.7%), followed by federal agencies investments of $43 billion (22.2%), and $21.7 billion (11.2%) invested by foundations, state & local governments, academic research institutions, and voluntary health associations. Thus, increasing investment in healthcare research and development will increase the utilization of research antibodies and reagents.
Reproducibility issues of antibodies and reagents is expected to hamper the growth of the research antibodies and reagents market.Reproducibility is the ability of an experiment or calculation to be duplicated by other researchers working independently.
The prevalence of irreproducible preclinical research exceeded 50%, resulting in approximately $28 billion spent on preclinical research every year.Among the irreproducible research, the largest fraction of about 36% is assigned to biological reagents, which amounts to $10 billion annually.
This huge research wastage expenses are due to insufficiently validated antibodies and irreproducible reagents that are not appropriate for the target proteins. Thus, reproducibility issues of antibodies and reagents are expected to restrain the market growth.
Technological advancements in the area of purification of antibodies and reagents show opportunities for the growth of the research antibodies and reagents market during the forecast period.Irreproducible antibodies and reagents are a major challenge for the industry as this will affect the outcome of the research.
In 2019, Genscript announced the launch of an AmMag technology, which is a semi-automatic purification instrument that accelerates the purification process from days to hours. The AmMag SA was developed under the license agreement with Amgen.
In 2019, LifeSpan BioSciences Inc, a US-based global molecular pathology company, acquired Everest Biotech Ltd for an undisclosed amount.The acquisition is expected to strengthen LifeSpan Biosciences’ position in the research reagent market and will broaden the product portfolio over 500,000 monoclonal and polyclonal primary antibodies to include virtually every protein in the proteome.
Everest Biotech is a UK-based anti-peptide and antigen affinity purified goat polyclonal antibodies manufacturer, which was established in 2000.
The countries covered in the research antibodies and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Our reports have been used by over 10K customers, including:
The global cell separation technologies market reached a value of US$ 7.62 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 19.28 Billion by 2027, exhibiting a CAGR of 16.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging...
120 pages •
By Infiniti Research Limited
• Jun 2022
Global Automated Liquid Handlers Market 2022-2026 The analyst has been monitoring the automated liquid handlers market and it is poised to grow by $ 242.84 million during 2022-2026, accelerating at a CAGR of 5.95% during the forecast period. Our report on the automated liquid handlers market provides a holistic analysis,...
The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1.69 Billion by 2027, exhibiting a CAGR of 7.81% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
120 pages •
By Infiniti Research Limited
• May 2022
Global Microarray Biochips Market 2022-2026 The analyst has been monitoring the microarray biochips market and it is poised to grow by $ 14.75 billion during 2022-2026, accelerating at a CAGR of 19.95% during the forecast period. Our report on the microarray biochips market provides a holistic analysis, market size and...
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2015-2022 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
Report Scope: This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies.The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively...
The Global Epigenetics Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 14.6% CAGR during the forecast period. Epigenetics is a field of genetics that examines cellular and physiological feature changes produced by environmental or environmental variables that switch genes on and off and alter the...
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Drugs In Development, 2022, provides an overview of the Genital Herpes (Infectious Disease) pipeline...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Automated Liquid Handling Systems Market 2022-2026 The analyst has been monitoring the automated liquid handling systems market and it is poised to grow by $ 768.06 mn during 2022-2026, accelerating at a CAGR of 12.23% during the forecast period. Our report on the automated liquid handling systems market provides...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.